Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney (Renal Cell) Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05135832
What this trial is testing

Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney CancerKidney Neoplasm+3 more
Herlev and Gentofte Hospital 174
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Not applicableStudy completedNCT05976607
What this trial is testing

Clinical Study of 18F -FAPI-RGD in Renal Tumor

Who this might be right for
Renal Tumor
Sichuan Provincial People's Hospital 35
Large-scale testing (Phase 3)Study completedNCT03142334
What this trial is testing

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 994
Testing effectiveness (Phase 2)Ended earlyNCT00009919
What this trial is testing

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01048892
What this trial is testing

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Who this might be right for
Adrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more
Children's Oncology Group 22
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Testing effectiveness (Phase 2)Study completedNCT00630409
What this trial is testing

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Pittsburgh 5
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing

SAbR For Oligo-Progressive Renal Cell Cancer.

Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20
Not applicableStudy completedNCT01339975
What this trial is testing

Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma

Who this might be right for
CarcinomaCarcinoma Renal CellKidney Neoplasms+2 more
University Hospital, Bordeaux 310
Early research (Phase 1)Ended earlyNCT00960063
What this trial is testing

Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Who this might be right for
NeoplasmsSolid TumorsBone Cancer+2 more
Merck Sharp & Dohme LLC 4
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Testing effectiveness (Phase 2)Study completedNCT00003585
What this trial is testing

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
University of New Mexico 35
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Next Page